baber/WOPTO huggingface dataset:
Patent NZ-192187-A (NZ)
Title: Pasteurized intermediate moisture food product
Inventor: GIBBS V
IPC: A23L3/10
Filed: 1979-11-21
Abstract: Pasteurised food prod. of intermediate moisture content has water activity 0.86-0.91, and pH 4.5-5.5 and is pasteurised in packages which are hermetically sealed before, during or immediately after pasteurising. The specified water activity is achieved by drying the prod. (or one or more of its ingredients) and/or by incorporating a humectant. pref. a sugar, salt, polyol and/or water soluble acid. Pref. humectants are glycerol, sucrose, glucose, polypropylene glycol, NaCl and/or sorbitol. The pH is pref. adjusted with acetic, citric, lactic, malic or tartaric acids, glucono-delta-lactone or acidic Na pyrophosphate. The prods. have long-term storage stability without refrigeration. Compared with prods. of lower water activity they have superior quality (esp. because less humectant is needed); better heat exchange properties when reheated; and do not require addition of antimycotics.
Patent NZ-212461-A (NZ)
Title: Thymopoietin and spleenin like peptides
Inventor: GOLDSTEIN G
IPC: A61P37/04
Filed: 1985-06-18
Abstract: Immunoregulating peptides are disclosed which are more potent than thymopentin or splenin and are useful for their effects on the immune system, especially the treatment of thymic deficiencies.
Patent NZ-226769-A (NZ)
Title: Benzocycloheptene derivatives containing an aromatic carboxylic acid, ester or amide group
Inventor: KLAUS MICHAEL
IPC: C07C51/00
Filed: 1988-10-28
Abstract: Compounds of the general formula 
<IMAGE>
 in which
 R<1> denotes hydroxyl, lower alkoxy, amino, mono- or di-lower alkylamino;
 R<2> denotes hydrogen, alkyl, alkoxy or halogen;
 R<3>, R<4>, R<5>, R<6>, R<1><1> and R<1><2> independently of one another denote hydrogen or lower alkyl;
 R<3> and R<5> together denote a methylene or hydroxymethylene group;
 R<7>, R<8>, R<9> and R<1><0> denote hydrogen or lower alkyl; or
 R<1><1> and R<1><2> together denote an oxo group or spirocyclo-lower alkyl; or R<1><1> denotes hydrogen and R<1><2> denotes hydroxyl or acetoxy; and one of the radicals R<1><3> and R<1><4> denotes hydrogen and the other denotes lower alkyl or trifluoromethyl,
 and physiologically tolerable salts of carboxylic acids of the formula I can be used as medicines, in particular for the treatment of neoplasias, acne and psoriasis. The novel compounds can be prepared by synthesis of the C(R<1><3>)=C(R<1><4>) double bond according to Wittig from an appropriate bicyclic and an appropriate monocyclic component and, if appropriate, subsequent modification of functional groups.
Patent NZ-244490-A (NZ)
Title: Benzazepine-2-one derivatives and pharmaceutical compositions
Inventor: PEGLION JEAN-LOUIS
IPC: A61P9/06
Filed: 1992-09-25
Abstract: Compounds of formula (I): 
<IMAGE>
 in which p and q, which are identical or different, represent 0, 1 or 2 provided that the sum p + q is equal to 1 or 2. 
<??>These compounds are useful in the treatment of cardiovascular ailments.
Patent NZ-255922-A (NZ)
Title: Glucagon receptor, dna constructs and host cells therefor
Inventor: KINDSVOGLE WAYNE R
IPC: C12Q1/68
Filed: 1993-08-30
Abstract: The present invention provides isolated DNA molecules comprising a DNA segment encoding a glucagon receptor. Also provided are DNA constructs comprising a first DNA segment encoding a glucagon receptor operably linked to additional DNA segments required for the expression of the first DNA segment, as well as host cells containing such DNA constructs. The present invention also provides a method for detecting the presence of glucagon antagonists, comprising the steps of (a) exposing a compound in the presence of a glucagon against to a recombinant glucagon receptor coupled to a response pathway under conditions and for time sufficient to allow binding of the compound to the receptor and an associated response through the pathway, and (b) detecting a reduction in the stimulation of the response pathway resulting from the binding of the compound to the glucagon receptor, relative to the stimulation of the response pathway by the glucagon agonist alone and therefrom determining the presence of a glucagon antagonist.
Patent NZ-272000-A (NZ)
Title: Blood glucose analysis: body worn sensor transmits wireless signals to analyser
Inventor: BOCKER DIRK
IPC: A61B5/00
Filed: 1995-04-27
Abstract: The blood analysis system is used to monitor the glucose conc. of the blood using a sensor unit (2) attached to the body of the patient, with a sensor (7) measuring a parameter which is dependent on the glucose conc. and a transmitter for transmitting the obtained data to a central evaluation unit (3). Pref. the sensor unit uses light for detecting a physical parameter dependent on the glucose conc., the evaluation unit calibrating the received data with analysis data for the analysis element, held in a memory, to control a read-out display (21).
Patent NZ-318501-A (NZ)
Title: Novel composition containing an acid-labile omeprazole and process for its preparation
Inventor: SETH PAWAN
IPC: A61K9/54
Filed: 1996-09-23
Abstract: A pharmaceutical composition exempt of alkaline-reacting compounds comprising :     (a) a core containing an acid-labile omeprazole active principle,   (b) an intermediate layer ; and   (c) an enteric layer ; with the proviso that said composition is not an oral pharmaceutical multiple unit tableted dosage form comprising tablet excipients and individually enteric coating layered units of a core material containing omeprazole, covered with one or more layer (s) of which at least one is an enteric coating layer, whereby the enteric coating layer has mechanical properties such that the compression of the multiple unit tableted dosage form does not significantly affect the acid resistance of the individually enteric coating layered units.  Process for preparing a composition. <IMAGE>   <IMAGE>   <IMAGE>
Patent NZ-332011-A (NZ)
Title: 4-[(thien-2-yl)methyl]imidazole derivatives having a2-adrenoceptor agonistic activity
Inventor: BOYD ROBERT E
IPC: A61P25/04
Filed: 1997-03-26
Abstract: The 4-[(THIEN-2-YL)methyl]-imidazoles of the formula shown below wherein R is hydrogen or methyl; X is hydrogen, C1-4alkyl, bromine or chlorine; and Y is hydrogen, C1-4alkyl bromine or chlorine; with the proviso that X and Y are not both simultaneously hydrogen, have exceptional analgesic activity.
Patent NZ-332385-A (NZ)
Title: Pesticide containing a signal substance, UV absorber and a pesticidal compound
Inventor: HOFER DIETER
IPC: A01N25/18
Filed: 1997-05-02
Abstract: A flowable composition for controlling harmful insects and representatives of the order Acarina is claimed comprising: a) 40 to 98 % by weight of the UV absorber or the UV absorber mixture; b) 0.01 to 30 % by weight of one or more signal substance(s) and c) 0.1 to 20 % by weight of one or more pesticidally active compound(s) of the formulae (I) to (V) as defined in the specification.
Patent NZ-333606-A (NZ)
Title: Isolated peptides derived from MAGE-2
Inventor: MELIEF CORNELIS J M
IPC: A61K35/26
Filed: 1997-07-24
Abstract: An isolated peptide selected from the group: a) SEQ ID NO: 67:  Glyn Val Met Pro Lys Thr Gly Leu Leu Ile Ile and b) SEQ ID NO: 69:  Phe Leu Trp Gly Pro Arg Ala Leu Ile Glu Thr. The peptide is derived from the MAGE-2 molecule and binds to HLA-A2 molecules.
Patent NZ-334435-A (NZ)
Title: Protected optical fibre, fibres loose fit within casing
Inventor: DELROSSO GIOVANNI
IPC: G02B6/245
Filed: 1997-02-28
Abstract: A protected optical fibre includes a housing 200.  Optical fibres 270 pass through the housing and through an inner housing 260.  The fibre is positioned sufficiently loosely in the inner housing so that it is not subject to stresses when the housing deforms due to temperature variations.  The housing is in contact with a peltier cooler 240.
Patent NZ-336851-A (NZ)
Title: Transferring digitised image using array of point sources or detectors, scanned over square region of image
Inventor: VODOPIVEC JOZEF
IPC: G03F7/20
Filed: 1996-12-23
Abstract: A device for scanning and digitising an image, or for transferring a digitised image to photosensitive material uses an array 11 of point light sources or detectors.  Each source or detector is scanned over a square region 12 of the image or photosensitive material, so that each source or detector exposes or scans only a limited number of pixels, rather than all the pixels.  Where an image is being exposed, the point sources are turned on or off in accordance with the motion of the array.  The image or photosensitive material may be suspended above the array by air jets.
Patent NZ-502047-A (NZ)
Title: Pressurized liquefied natural gas fuel storage and delivery systems for natural gas powered vehicles
Inventor: BOWEN RONALD R
IPC: F25J1/02
Filed: 1998-06-18
Abstract: Fuel storage and delivery systems are provided for storing pressurized liquefied natural gas (PLNG) fuel at a pressure of about 1035 kPa (150 psia) to about 7590 kPa (1100 psia) and at a temperature of about -123 degree C to about -62 degree C; and for delivering vaporized PLNG fuel on demand for combustion in an engine. The fuel storage and delivery system comprises: a)  fuel storage containers (10) that are constructed from ultra-high strength, low alloy steel containing less than 9 wt.% nickel and having a tensile strength greater than 830 MPa (120 ksi) and a DBTT lower than about -73 degree C. b)  a fill and vent valve (13) for allowing transfer of PLNG fuel between the fuel storage container (10) and a refuelling station; c) a liquid line (8) for allowing flow of liquid PLNG fuel from the fuel storage container to a vaporizer (20); d) a vapour line (9) for allowing flow of vaporized PLNG fuel from the fuel storage container to the vaporizer (20); e) a fuel line (4) for allowing flow of vaporized PLNG fuel from the vaporizer (20) to the engine (24); and f) a fuel regulator (22) for regulating flow of vaporized PLNG fuel from the vaporizer (20) to the engine (24). The fuel storage containers are useful for automobiles, buses, trucks and other vehicles with engines designed to operate through combustion of natural gas.
Patent NZ-506462-A (NZ)
Title: Substituted pyridino arylpiperazines, pharmaceuticals thereof, and their use in the treatment of benign prostatic hyperplasia or any diseases associated with alpha-1a adrenergic receptors
Inventor: KUO GEE-HONG
IPC: C07D213/82
Filed: 1999-02-19
Abstract: A series of heterocyclic substituted piperazines of formula (I), methods of treatment, pharmaceutical compositions containing them, and intermediates used in their manufacture is disclosed, wherein the variables shown in formula (I) are as described in the specification. These compounds of formula (I) selectively inhibit binding to the alpha -1a adrenergic receptor, a receptor that has been implicated in benign prostatic hyperplasia and as such they are potentially useful in the treatment of this disease.
Patent NZ-508386-A (NZ)
Title: 2-(3,5-bis-trifluoromethyl-phenyl)-N-methyl-N-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramide for treating diseases associated with neurokinin-1 (NK-1) activity
Inventor: BALLARD THERESA MARIA
IPC: A61K31/00
Filed: 2000-11-23
Abstract: A compound of the formula shown or a pharmaceutically acceptable acid addition salt thereof, process of making the compound and method of treating diseases associated with NK-1 receptor are described.
Patent NZ-508894-A (NZ)
Title: Removable container floor with channels to facilitate the lifting of a product
Inventor: MCDOUGALL JOHN CAMPBELL
IPC: B65D90/00
Filed: 1999-05-21
Abstract: A removable floor (1) for a shipping container, which will lie over the existing container floor, has a plurality of spaced apart elongate channels (7), which can receive the "skates", which can lift the product above the removable floor (1) as it is moved into position in the container. The removable floors (1) can be moved between containers and between different locations.
Patent NZ-508933-A (NZ)
Title: Methods and apparatus for rendering an optically encoded medium unreadable by deforming the medium that is responsive to a read out beam
Inventor: LAWANDY NABIL M
IPC: G11B7/24
Filed: 1999-06-25
Abstract: Methods and apparatus are provided for making an optically readable media (20) unreadable. The method includes steps of (a) providing the media (20) with an optically activated mechanism that degrades the reflectivity of a surface wherein information is encoded; (b) exposing the media (20) to optical radiation for reading out the information; and, during the step of exposing, (c) initiating the operation of the optically activated mechanism. In a further aspect the optically activated mechanism causes a defocusing of a readout beam, thereby degrading reflection of the readout beam from a surface wherein information is encoded. In another embodiment the method deforms a surface of the layer resulting in readout beam aberration or in an inability to correctly stay on track. In another embodiment a portion of the surface is removed to the atmosphere, such as by evaporation or sublimation.
Patent NZ-510512-A (NZ)
Title: Moraxella catarrhalis BASB034 polypeptides and uses thereof
Inventor: RUELLE JEAN-LOUISE
IPC: C12N1/21
Filed: 1999-09-14
Abstract: Describes a method providing BASB034 polypeptides and polynucleotides encoding BASB034 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
Patent NZ-511427-A (NZ)
Title: A method for supplying bioavailable isopropyl ester of the hydroxy analogue of methionine to a cow
Inventor: ROBERT JEAN-CLAUDE
IPC: A23K1/16
Filed: 1999-11-10
Abstract: A method for supplying bioavailable methionine to a cow, which comprises supplying to the cow an ester of methionine, which is an isopropyl ester of the hydroxy analogue of methionine, is disclosed, wherein the method is intended to modify the composition of milk obtained from dairy cows.
Patent NZ-513515-A (NZ)
Title: Variable capacitance coupling antenna particularly for smart cards
Inventor: MATHIEU CHRISTOPHE
IPC: H01Q1/22
Filed: 2001-01-02
Abstract: A coupling antenna connected to a device transmitting/receiving electromagnetic waves containing one or several integrated capacitors. Said coupling antenna comprises at least a turn (24) screen printed on a support (28) consisting of an insulating dielectric substrate and further comprises a capacitor screen printed on the support, connected in parallel, thereby enabling to reduce the capacitance supplied by the capacitor(s) incorporated in the device, so that the resulting capacitance forms a resonating circuit with the turn. The invention also concerns the method for making such an antenna and the use of said antenna in a non-contact or hybrid contact smart card.
Patent NZ-514728-A (NZ)
Title: IL-8 receptor antagonists
Inventor: PALOVICH MICHAEL R
IPC: A61P19/10
Filed: 2000-05-26
Abstract: Compounds of formula (I) and the use thereof to treat chemokine mediated disease states, wherein the chemokine binds to an IL-8 a or b receptor.
Patent NZ-515091-A (NZ)
Title: Method and apparatus for manufacture of a plastic bag with standup bottom wall
Inventor: PANSIER DONALD J
IPC: B31B50/25
Filed: 2000-05-15
Abstract: The bag is formed with an open end and a opposite spaced end seal. Hinge crease patterns (6, 6a) are formed in each of the gusseted portions at the bottom end of the bag. A web supply is passed through a web feed supply section to form a gusseted web. The gusseted web is sent through a forming section. The segment is first formed with the pattern of two bags in immediately adjacent relationship and located to the opposite sides of a common line defining the end of the adjacent bags. The web is formed into two bag segments with the creases located at each of the segment ends. The web is passed through a unit creating the seal and simultaneously severing the upstream segment. The segments are stacked on a table with each stack sequentially transferred to a punch unit which severs the centre portion of the segment to define open bag ends adjacent each other with interconnections to maintain the stack relationship between the separated bags. The bag may be formed with ventilation openings at the punch unit. The crease pattern with the bottom portion includes a plurality of creases to ensure the proper location of at least one crease within the gusseted portion to ensure easy opening of the plastic bag.
Patent NZ-519259-A (NZ)
Title: Liquid dispensing toilet rim mounted toilet bowl cleaner
Inventor: LEONARD STEPHEN B
IPC: E03D9/03
Filed: 2000-12-13
Abstract: A liquid dispenser 10 for dispensing a liquid from the rim of a toilet bowl such that a controlled, consistent amount of liquid is dispensed into each flush has a bottle 18 for holding the liquid, a base 24 for holding the bottle and for providing a liquid feed conduit between the bottle and a dispensing plate 40, and a hook 12 for suspending the base from the rim of the toilet bowl. The dispensing plate 40 is integral with or attached to the base, and serves to distribute liquid from the feed conduit to a dispensing position on the upper surface 42 of the dispensing plate where the liquid is contacted by flushing water from the toilet bowl. The dispensing plate has various configurations that assist in the distribution of the liquid to the dispensing position on the upper surface of the dispensing plate. In a preferred version of the liquid dispenser, the dispensing plate has capillary channels 48 in its upper surface 42 for distributing the liquid from the feed conduit to the dispensing position.
Patent NZ-519363-A (NZ)
Title: A novel drug dosing regimen
Inventor: HEATH DAVID DUNCAN
IPC: A61K9/22
Filed: 2002-06-05
Abstract: A process for administering to an animal progressively increasing doses of one or more biologically active agents which are released over a predetermined period of time from a delivery means which is administered to an animal on a single occasion.
Patent NZ-520340-A (NZ)
Title: Electronic alarm timer and status or action diary display for use with a medical regimen
Inventor: VAN DULLEMEN MARLIES
IPC: G04G99/00
Filed: 2001-02-19
Abstract: An electronic alarm timer for use with a medical regimen, in particular for a contraceptive, comprises a housing (1) containing a control unit (2) having a timer (3). Indicating means on the housing are connected to the control unit in order to show information by means of graphical representations (5). Also timed alarm means (4) are connected to the control unit. The control unit and the indicating means are adapted to show information about the desired status of the medical regimen. The control unit and the indicating means are also adapted to show information about the acts to be performed.
Patent NZ-520502-A (NZ)
Title: 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
Inventor: PEASE ELIZABETH JANET
IPC: A61K31/506
Filed: 2001-02-26
Abstract: Pyrimidine derivatives of formula (I), pharmaceutically acceptable salts and in vivo hydrolysable esters thereof, processes for their manufacture, pharmaceutical compositions and their use as cyclin-dependent serine/threonine kinase (CDK) and focal adhesion kinase (FAK) inhibitors are disclosed, wherein: Q1, Q2, G and R1 are as in the specification.
Patent NZ-521517-A (NZ)
Title: Protection of oxygen sensitive oils by encapsulating the oil with a film forming protein reacted with a carbohydrate having reducing sugar groups which reaction forms Maillard reaction products
Inventor: AUGUSTIN MARY ANN
IPC: A23L27/21
Filed: 2001-04-03
Abstract: A powder contains an oxygen sensitive oil obtained by drying an emulsion of the oil. The oil is encapsulated within a film forming protein, which, prior to drying to form the powder, has been heated in solution, in the presence of a carbohydrate, for a time to provide sufficient Maillard reaction products to provide resistance to oxidation. A method of forming an emulsion of an oxygen sensitive oil comprises: a) preparing an aqueous mixture of a protein and a carbohydrate which contains a reducing sugar group; b) heating the mixture from 60 to 160oC for a period to allow sufficient Maillard reaction products to form without coagulation consuming at lest 10% of the sugar to provide resistance to oxidation; c) dispersing said oil in the aqueous phase and d) homogenising the mixture to obtain an emulsion which can be dried to produce a powder.
Patent NZ-534486-A (NZ)
Title: Aqueous traffic paint and method of application
Inventor: HERMES ANN ROBERTSON
IPC: B05D5/06
Filed: 2004-08-03
Abstract: Disclosed herein is an aqueous traffic paint comprising: (a) hard-soft polymer particles comprising pendant acid-functional groups, wherein each of said hard-soft polymer particles comprise, based on weight of said hard-soft polymer particles: (i) from 65 to 95 weight % of a soft polymer having a glass transition temperature in the range of from -40 to 20 DEG C, and (ii) from 5 to 35 weight % of a hard polymer having a glass transition temperature of at least 40 DEG C; wherein said hard-soft polymer particles have a Hansch parameter of at least 3, wherein the Hansch parameter being calculated based on a weight average of monomer units forming the hard-soft polymer particles; (b) a polyfunctional amine; and (c) an amount of volatile base sufficient to raise the pH of said aqueous traffic paint to a point where substantially all of the polyfunctional amine is in a non-ionic state. The aqueous traffic paint may further comprise a photosensitive composition and a silane functional compound. Also disclosed is a method of producing a traffic marking on a road surface using the aqueous paint. This aqueous traffic paint is suitable for application to road surfaces, including oily road surfaces, and may be applied at temperatures below 15 DEG C.
Patent NZ-536369-A (NZ)
Title: Cheese capable of disinfecting helicobacter pylori
Inventor: HAYASHI SHUNJI
IPC: A61P31/04
Filed: 2003-04-11
Abstract: Disclosed is a natural cheese which comprises a lactic acid bacterium belonging to Lactobacillus gasseri having a disinfection potency against Helicobacter pylori. Further disclosed are a process for the production of the cheese, and foods comprising the cheese.
Patent NZ-536570-A (NZ)
Title: Methods and compositions for treating flaviviruses and pestiviruses
Inventor: SOMMADOSSI JEAN-PIERRE
IPC: A61P31/14
Filed: 2001-05-23
Abstract: Disclosed is the use of nucleoside compounds in the manufacture of a medicament for the treatment of a flavivirus or pestivirus infection, wherein: Base is a purine or pyrimidine base, R1 is H, mono, di or triphosphate, stabilised phosphate prodrug, acyl, an amino acid ester, carbohydrate, a peptide, or other pharmaceutically acceptable leaving group capable of providing a H or phosphate substituent, and R6 is alkyl, alkynyl, alkenyl, and R9 and R7 are independently OR1, hydroxyl, or -O(acyl).
Patent NZ-538158-A (NZ)
Title: Meat substitute product for savoury or sweet snack, comprising forming homogenous mixture of powdered milk, whey protein, an alkali metal and ammonium caseinate
Inventor: KWELDAM ADRIAAN CORNELIS
IPC: A23L29/294
Filed: 2002-09-17
Abstract: A method for the preparation of a meat substitute product is described. The method comprises protein, wherein: i) a protein material, a hydrocolloid which precipitates with metal cations and water are added to one another, ii) the composition from step i) is formed into a homogenous mixture, iii) the mixture from ii) is mixed under stirring with a solution of a metal cation with a valency of at least 2, in order to form a fibrous product, iv) the fibrous product is isolated, wherein the protein material comprises a milk protein material selected from powdered milk, whey protein and alkali metal, alkaline-earth metal and ammonium caseinate or mixtures of these materials. (62) Divided out of 534707